Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Otsuka's new anti-H. pylori agents for GI disorders

Feb. 10, 1999

Antiulcer benzimidazoles discovered by Dr. Reddy's group

Feb. 8, 1999

Gastric antisecretory and gastroprotective compounds in development at Byk Gulden

Feb. 8, 1999

Viragen completes toxicology studies of Omniferon

Feb. 5, 1999

Enzon initiates phase III trials of PEG-Intron/Rebetol combination therapy for hepatitis C

Feb. 3, 1999

Carrington announces plans for phase III testing of Aliminase

Jan. 28, 1999

Anti-TNF MAb reduces circulating levels of sPLA2 in Crohn's disease patients

Jan. 28, 1999

Disaccharidase inhibitor as adjunctive therapy in portal-systemic encephalopathy

Jan. 27, 1999

Patent coverage sought by Viragen for second-generation interferon product

Jan. 26, 1999

Preclinical study results support development of antiulcer agent TU-199

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026